Navigation Links
Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis
Date:12/2/2009

sition as it explores additional, first-in-class opportunities for the candidate drug and other compounds for the topical treatment of dermatological infections, such as impetigo and infected wounds and burns."

The rapid resistance development by microbes limits the use of classical antibiotics for indications such as atopic dermatitis, especially for topical applications. DermaGen's AMP is derived from natural endogenous human proteins and there is low probability that it will induce resistance as it lack a specific molecular target on bacteria and other microbes. Anti-infective treatments represent the most important component of the global dermatology market, accounting for 31% of total market value, approximately USD 4 billion.

Conny Bogentoft, CEO of Karolinska Development, said, "Pergamum and its Operating Units form an important part of the Karolinska Development portfolio. They represent a strong offering in dermatology and wound healing markets with products targeting indications with significant unmet medical needs. It is encouraging to see the progress they are making in their clinical development programs."

About DermaGen

DermaGen AB is a specialty pharmaceutical company and world leader in the research and development of endogenous antimicrobial peptides. Founded in 2004, DermaGen focuses on the development of topically applied products for the prevention and treatment of bacterial and fungal skin infections. Novel antimicrobial peptides are modified to increase their potency and stability, facilitating the development of pharmaceutical products that fulfill unmet medical needs and significantly improve quality of life for patients. DermaGen partners with leading international pharmaceutical companies in the dermatological field to ensure rapid and cost-efficient development. The company is based in Lund, Sweden and is part of the Pergamum group of companies.

'/>"/>

SOURCE DermaGen AB
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. DermaGen AB Receives Over 1 Million Euros From a New Share Issue
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. Spherix Reports Second Quarter Earnings
4. Tapestry Reports Second Quarter 2007 Results
5. Callisto Reports on Second-Quarter 2007 Milestones
6. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
7. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
8. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
9. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
10. Biopure Reports on Meeting with the FDA
11. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... Ill. , April 17, 2015  AbbVie Inc. ("AbbVie") ... announced that it has extended the expiration of its exchange ... stock of Pharmacyclics, Inc. to 5 p.m., New ... On April 17, 2015, AbbVie also voluntarily withdrew ... Improvements Act in order to provide the FTC with additional ...
(Date:4/17/2015)... 2015 Inivata, a Cambridge, ... their presence at the 2015 American Association for Cancer Research ... Nitzan Rosenfeld and a poster presentation. Michael ... - 22 nd . The presentation, entitled ... , forms part of a session on Recent ...
(Date:4/17/2015)... 17, 2015 Research and Markets ( ... "Medical Equipment Rental and Leasing - Global Strategic Business ... report analyzes the worldwide markets for Medical Equipment Rental ... comprehensive analytics for the US, Japan ... World. Annual estimates and forecasts are provided ...
Breaking Medicine Technology:AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 2AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 3AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 4Inivata Co-founder Nitzan Rosenfeld to Present at AACR Annual Meeting 2Medical Equipment Rental and Leasing Market 2015-2020 - Global Strategic Business Report - Healthcare Spending Slowdown Bodes Well for Medical Equipment Leasing 2
... UCB offers Cimzia(R) (certolizumab pegol), a treatment option ... arthritis and moderate to severe Crohn,s disease, to ... resulting from the UCB partnership with OXO(R) ... and OXO(R) in the development of the new ...
... Results Show Superior Decrease in Pain Scores Compared to ... presented the results of a six-month safety and efficacy ... at decreasing the pain of knee osteoarthritis (OA) at ... is superior to saline in decreasing pain at 26 ...
Cached Medicine Technology:Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 2Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 3Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 4Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 5Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 6Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 7Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 8Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 9Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 10Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 11Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain 2Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain 3
(Date:4/19/2015)... The American Association for Physician Leadership® ... the inaugural winner of the Roger Schenke Award. The ... 18, in Las Vegas, Nevada. , Ellner, president ... the department of surgery and director of surgical quality ... Connecticut, was instrumental in the founding of the Connecticut ...
(Date:4/19/2015)... Lowcostcarinsuranceprice.com has released a new ... get drivers arrested for DUI. The blog post also ... premiums . , Some pills can have dangerous ... Drivers who are under medication should ask their doctor’s ... pills can be considered driving under the influence and ...
(Date:4/19/2015)... York (PRWEB) April 19, 2015 New ... Multidistrict Litigation (JPML) indicate that Lipitor lawsuits ( http://www.lipitorlawsuitcenter.com/ ... in U.S. District Court, District of South Carolina. According ... cases have been filed in the proceeding on behalf ... to their use of the cholesterol-lowering statin. This represents ...
(Date:4/19/2015)... 2015 McCann Investigations, a Texas-based full ... publication of white paper Married, but Dating: The ... online media provides a unique environment of privacy, anonymity ... targeting adulterous spouses has emerged. Social platforms which ... easy as shopping online. Dating sites and mobile ...
(Date:4/19/2015)... Wisconsin Dells, WI (PRWEB) April 19, 2015 ... solutions designer announces that it will exhibit it’s ... Conference and Expo and the Iowa-Illinois Safety Council Professional ... Go 6350 and the TaskMate EZ are used in ... and healthcare facilities. , Built to clamp to ...
Breaking Medicine News(10 mins):Health News:Dr. Scott Ellner named inaugural Roger Schenke Award winner 2Health News:Dr. Scott Ellner named inaugural Roger Schenke Award winner 3Health News:Driving On Medication - Possible Effects On Auto Insurance Prices 2Health News:Lipitor Lawsuits Mount, as New Court Report Shows More Than 100 Filings Added to Federal Litigation Since March 2Health News:Lipitor Lawsuits Mount, as New Court Report Shows More Than 100 Filings Added to Federal Litigation Since March 3Health News:McCann Investigations Publishes White Paper Married, but Dating: The Rise of the Married Online Affair 2Health News:HealthPostures' TaskMate Products to be Exhibited at the Wisconsin and Iowa-Illinois Safety Conferences 2
... , , , ... a major expansion to its product offering with the ... (MAPS) and the integration of the ClearPoint Security Performance ... solution - The ClearPoint Unified Security Performance and Compliance ...
... , , ... Oz Show," a high octane, multi-topic hour-long series hosted by trusted ... premieres in syndication today (check local listings). Episodes airing ... Team Oz" guest contributors, fashion and style expert Tim Gunn ("Project ...
... , MealsMatter.org Offers Delicious Ways to Keep the ... Sept. 14 As flu season grips the nation with heightened awareness ... method getting left out in the cold. , , ... groups throughout the year, but it,s particularly significant during flu season," said ...
... ... the results of the largest study ever performed of tubal reversal surgery, ... is more successful than IVF for couples wanting more children after a ... of the tubal reversal patients had reported pregnancies. "A simple one-hour outpatient ...
... , , , PITTSBURGH, Sept. ... Inc. is prototyping an innovative stroke treatment device designed to speed ... , , Michele Migliuolo, NeuroInterventions President ... a presentation at the 3 Rivers Venture Fair in Pittsburgh on ...
... works in different way than standard medicines , SUNDAY, ... people whose high blood pressure cannot be controlled by ... researchers report. , Substantial reductions in blood pressure were ... people who were still hypertensive despite trying three or ...
Cached Medicine News:Health News:ClearPoint Announces Metric Applications Packages for PCI DSS, NERC, Healthcare Compliance and FISMA 2Health News:ClearPoint Announces Metric Applications Packages for PCI DSS, NERC, Healthcare Compliance and FISMA 3Health News:ClearPoint Announces Metric Applications Packages for PCI DSS, NERC, Healthcare Compliance and FISMA 4Health News:'The Dr. Oz Show' Premieres Today Nationwide 2Health News:'The Dr. Oz Show' Premieres Today Nationwide 3Health News:'The Dr. Oz Show' Premieres Today Nationwide 4Health News:'The Dr. Oz Show' Premieres Today Nationwide 5Health News:Protect Your Family With Flu-Fighting Foods 2Health News:Study Shows Tubal Reversal Surgery is the Best Treatment to Have More Children After a Tubal Ligation 2Health News:Rapid-response Technology from NeuroInterventions, Inc. Aims to Quickly Restore Brain's Blood Flow After a Stroke 2Health News:Drug Offers Hope Against Tough-to-Treat Hypertension 2Health News:Drug Offers Hope Against Tough-to-Treat Hypertension 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: